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Background
More than thirty years have elapsed since the first AIDS cases were reported by the Centers for Disease Control and Prevention (CDC) in major US cities. Globally, there were approximately 36.7 (95%CI: 34.0-39.8) million people living with HIV/AIDS (PLWHA) and 2.1 (95%CI: 1.8-2.4) million people becoming newly infected with HIV at the end of 2015. HIV continues to be a major global public health issue, having claimed more than 35 million lives so far. In 2015, 1.1 (95%CI: 940,000-1.3 million) million people died from HIV-related causes globally 1 .
In 1996, Brazil became the first middle-income country to guarantee free and universal access to HIV treatment through its Brazilian Unified National Health System (SUS) 2 . Between 1980 and June 2016, 842,710 cases of AIDS were reported, and there were 487,000 PLWHA receiving highly active antiretroviral therapy (HAART) in Brazil in June 2016 3 .
In December 2013, the country implemented HIV Treatment as Prevention (TasP), allowing for treatment to be initiated immediately after confirmation of an HIV diagnosis, an approach intended to improve the quality of life for PLWHA and reduce the likelihood of HIV transmission 4, 5 . This initiative lead to a remarkable increase in PLWHA starting HAART in Brazil, from 48,696 to 81,177 in 2012 and 2015, respectively. Since 2015, 90% of patients receiving HAART in the country had been virally suppressed 6 . The efficacy of pre-exposure prophylaxis (PrEP) and its feasibility implementation in Brazil was recently demonstrated 6, 7 and the strategy has been scheduled to be offered by the SUS from 2017 onwards, with some uneven outcomes due to ongoing budget restraints.
In spite of those initiatives, AIDS-related deaths have remained stable over the last decade: 5.9 deaths per 100,000 inhabitants in 2006 and 5.6 deaths per 100,000 inhabitants in 2015. HIV prevalence among the general population has remained stable as well, at approximately 0.6% since 2004, being highly concentrated in the most of the vulnerable groups 3 . A systematic review followed by a meta-analysis identified a combined HIV prevalence for female sex workers of 6.2 (95%CI: 4.4-8.3); 13.6 (95%CI: 8.2-20.2) among men who have sex with men, and 23.1 (95%CI: 16.7-30.2) among people who use drugs 8 .
People who inject drugs (PWID) had a pivotal role in the Brazilian epidemic in the late 1980s, the 1990s, and the early years of the 21st century 8 , but due to a complex combination of different factors 9 , HIV/AIDS among PWID has declined in recent years. However, AIDS rates have been increasing among other socially disadvantaged populations 10 , with notable regional disparities between HAART uptake 11 and retention of patients in treatment. PWID and other marginalized and socially-disadvantaged populations usually start HAART in the later stages of infection 12, 13, 14 compared to MSM who generally start HAART earlier and have better access to health services, higher adherence to treatment and longer survival times after HIV/AIDS diagnosis 15, 16, 17 . Among heterosexuals, patients from impoverished social strata have higher mortality rates, findings that have been linked to factors such as low education, unemployment, unstable housing, and high transportation costs. These trends have been observed in Brazil as a whole as well as in the city of Rio de Janeiro 18, 19 .
Three decades later, AIDS is an urban epidemic in Brazil, clustered in the metropolitan areas of large cities such as Rio de Janeiro, among others. The city is located in the Southeast region of Brazil, a region concentrating 53% of all AIDS cases reported nationwide. During the last decade, Brazil has registered around 20.7 AIDS cases per 100,000 inhabitants, while Rio de Janeiro registered 34.1 cases per 100,000 inhabitants in 2006, and 27.8 cases per 100,000 inhabitants in 2015. AIDS-related deaths are also higher in Rio de Janeiro − the city accounted for 8.7 deaths per 100,000 inhabitants in 2015, while Brazil registered 5.6 deaths per 100,000 inhabitants in the same year 20 .
Although in recent years epidemiological studies on AIDS have been conducted nationwide 21, 22, 23, 24 , they do not always gather information that can adequately be applied to the State or regional levels. This study evaluated the disparities in HAART uptake and its impact on survival in the city of Rio de Janeiro from 2000 to 2011 in an effort to inform evidence-based policies in HIV-care in the local level.
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Methods
We studied trends in survival among PLWHA by combining data from four national information systems: Brazilian Information System for Notifiable Diseases/AIDS (SINAN/AIDS), National Database for Laboratory Tests (SISCEL), Logistics Control System of ARV Medicines (SICLOM) and Brazilian Mortality System (SIM). Data from PLWHA diagnosed between 2000 and 2011 in Rio de Janeiro city were extracted from those datasets and merged.
Only individuals whose self-reported exposure categories were PWID, men who have sex with men (MSM) or "heterosexuals" were included in the survival analysis. The following cases of AIDS belonging to other categories of exposure were excluded from the survival analysis: blood transfusion, vertical transmission (mother-to-child), accidents with biological material, and hemophiliacs. All these categories corresponded to less than 1.5% of the cases reported in the study period.
Database linkage
Probabilistic record linkage (PRL) is based on a likelihood score that measures the degree of similarity of several matching variables. Since differential information is found in each database, comprehensive analyses must use data from all of them. Following the methods proposed by Camargo Jr. & Coeli 25 , as a first step, we standardized the different databases in order to have exactly the same variable names, lengths and formats throughout all of them. An identification key was created for each patient, therefore enabling his unique identification in different databases. New variables were created using the patient's first and last name (PBLOCO and UBLOCO), date of birth, and mothers' name. The method consisted of cleaning and linking the databases using five blocking steps as follows: (1) . A cut-off score of 9.6 was used in all steps, trying to maximize sensitivity and minimize the need to perform manual review of pairs as much as possible. Unknown pairs were manually reviewed 26 .
Statistical analyses
As a first step, an exploratory analysis was carried out, considering both sociodemographic and clinical variables for each one of the exposure categories under analysis. Pearson's chi-square test was used for the assessment of independence, using 0.05 as the a priori statistical significance and taking as outcomes: AIDS death, HAART uptake after diagnosis, and CD4+ exam at baseline.
For the survival analysis, the outcome was mortality from AIDS-related causes during the followup period. Survival was calculated as the time elapsed from the date of AIDS diagnosis until the date of the AIDS-related death (or censoring). All deaths from other causes were considered censored data at the date of its occurrence, and individuals who remained alive were censored on December 31 st 2011. The independent variables were: exposure category, year of diagnosis, sex, age, ethnicity, level of education, first CD4+ cell count (cells/mm 3 ), first HIV-1 RNA viral load exam (log 10 ), and HAART uptake after diagnosis.
The variables CD4+ cell count and HIV-1 RNA viral load exam were categorized according to the international classification for CD4+ (cells/mm 3 ) and viral load levels 27 . The normality of these variables was verified by graphical methods and the Kolgomorov-Smirnov normality test. Both violated the normality assumption. Therefore, for HIV-1 RNA viral load, the log 10 transformation was used with the following categories: "< 4.00" (from 50 to < 10,000 copies, indicating low viral load); "4.00-4.99" (> 10,000 to < 100,000 copies, which indicates intermediate viral load); and "> 5.00" (> 100,000 copies, which indicates high viral load).
We used semi-parametric modeling, with single and multiple-covariate Cox models 28, 29 , first with the entire population selected (N = 15,420), adjusted for each exposure category. The likelihood ratio test p-value < 0.05 was used to select variables to be entered in the multiple-covariate Cox models, adjusting for potential confounders and testing for effect modification. The crude and adjusted hazard ratios (HR) and their 95% confidence intervals (95%CI) were used to evaluate the effects obtained by single and multiple-covariate Cox models, respectively. The coefficient R 2 was used to show the explanatory capacity of final Cox models. The proportional hazards assumption was assessed by the visual inspection of Schoenfeld's residuals 30 (see Supplementary Material: http://cadernos.ensp. fiocruz.br/csp/public_site/arquivo/csp-0096-17-supplementary-material_1717.pdf). This analysis made evident the violation, even small, of the proportional hazard assumption by the variable "HAART uptake after diagnosis", and by the isolated categories "CD4+ cell count unspecified" and "HSH".
As the sample has a considerable size, it was understood that any lack of proportionality can establish a violation of risk proportionality (a basic assumption of the original Cox model), so extended Cox models were fitted instead 28 . Then, we fitted separated extended Cox models for each exposure category in order to analyze possible inequalities between them. Likewise, Schoenfeld's residuals analysis was performed for each one of the three extended models. To better illustrate the (putative and actual) violations of proportionality, a web appendix with selected plots of some of the original analysis of residuals was made available as part of the manuscript (see Supplementary Material: http://cadernos. ensp.fiocruz.br/csp/public_site/arquivo/csp-0096-17-supplementary-material_1717.pdf).
The Brazilian city of Rio de Janeiro, capital of the homonymous state, located in the Southeast region of the country, is subdivided into 33 administrative regions, which are regional divisions organized by the State to facilitate the administration and governance of a country 31 . Due to the heterogeneity of the municipality of Rio de Janeiro, we used a random effect to evaluate the potential association of survival in a given cluster of neighborhoods of residence in the city (administrative regions) by using the gamma distribution of frailty 32, 33, 34 .
The linkage process was performed using the software RecLink 3.1 35 . Survival analysis was performed with the help of R's "survival" library (http://CRAN.R-project.org/package=survival), 
Results
Overall, considering all the 43,199 individuals identified as being AIDS cases through the linkage procedure, 45.8% had no information about laboratory exams. For 7.6% of cases, information was exclusively available at SIM, corresponding to AIDS-related deaths of individuals who were not reported as "AIDS cases" by the other three databases (i.e. they were not registered as AIDS cases, never received HAART, neither performed any laboratory exam).
From 2000 to 2011, 43,199 AIDS cases were reported in Rio de Janeiro city, most (64.3%) of them male, with a mean age of 38.6 years [standard deviation (SD) = 11.1]. Roughly similar proportions of "whites" (37.5%) and "non-whites" (38.8%). Roughly one quarter of cases (23.7%) had no information on ethnicity. The majority had less than eight years of formal education (35.1%). During the period, 10,569 deaths (24.5%) were reported, of which 84.7% were AIDS-related. Average survival time after AIDS diagnosis was 4.72 years (SD = 3.74), with a median survival of 4.41 years.
The 12 years of follow-up were further divided in three periods of four years each (2000-2003, 2004-2007, and 2008-2011) ; with a roughly similar number of AIDS cases in each proportion of patients who had at least one CD4+ count and HIV-1 RNA viral load exam period. Access to CD4+ and HIV-1 RNA viral load exam increased over time (from 50.2% to 53% and from 43% to 50.6%, respectively), as well as the proportion of patients receiving HAART, which also increased, from 55.8% to 59.8%.
Non-white individuals, those with less than eight years of formal education, and people who inject drugs (PWID) were more likely to die of AIDS and less likely to receive HAART. People who had at least one CD4+ and one viral load exam registered were more likely to receive HAART and, Cad. Saúde Pública 2018; 34(8):e00009617 consequently, less likely to die of AIDS, compared to those who did not have those exams registered (Table 1) . Among the 43,199 AIDS cases reported, 15,420 with exposure category information were selected for the current analysis. Heterosexuals accounted for 60.7% of AIDS cases, followed by 36.1% MSM and 3.2% PWID. The mean age was 38.05 (SD = 10.65). Most of reported AIDS cases occurred in men (63%), non-whites (43%), and people with up to primary education (53.4%). HAART uptake after AIDS diagnosis increased slightly during this 12-year period (62.7% to 65.1%) and was lower among PWID, when compared to MSM and heterosexuals (Table 2) .
Roughly half of the patients had CD4+ and HIV-1 RNA viral load exams registered at a public health facility, and PWID were less likely to have ever conducted those exams. Among those with available results, PWID had lower mean CD4+ count and higher HIV-1 RNA viral load counts. During this period, 2,807 deaths were reported (18.2% from total), 77.2% of those AIDS-related deaths. Mortality from all causes was 2.2 times higher among PWID when compared to MSM, while AIDSrelated deaths were similar among the exposure categories under analysis ( Table 2) .
The overall AIDS-related survival rate was 85.9% in 12 years, with a mean of 5.92 years (SD = 3.63) and median of 6.29 years. Both AIDS-related deaths and deaths due to any non-AIDS cause significantly decreased during the period. AIDS-deaths (2,167) declined from the first to the last period (1,061; 781; 325). Deaths due to other causes (640) declined also (364; 203; 73).
The AIDS epidemic in Rio de Janeiro city is mostly composed by heterosexual cases, with a slightly decrease over the follow-up period (63.4 to 52.5%), while the magnitude of cases among PWID remains negligible and has been decreasing over time (3.7% to 2.5%). Among MSM an increasing trend can be observed over time, from 32.9% to 45% ( Table 2) .
As expected we found a significant interaction between the two laboratory variables (CD4+ counts and HIV-1 RNV viral load). Baseline CD4+ count (cells/mm 3 ) is predictive of virologic failure and AIDS-related mortality 36, 37 and, due to the strong interaction between these two laboratory variables, we decided to exclude HIV-1 RNA viral load from our final model. We also identified a significant interaction between education and ethnicity, and decided to include it in our final models ethnicity instead of education level as the key socioeconomic status variable. This decision was based in previous and robust evidence of the disproportionate burden of HIV/AIDS, late entry into HIVtreatment, and higher AIDS-related mortality among non-white patients 38, 39 . The variables sex and year of diagnosis were not significant in the bivariate analysis. Therefore, our final models included age, ethnicity, CD4+ counts, HAART uptake, and exposure category (Tables 3 and 4) .
The results depicted in Table 4 show an increased risk of AIDS-related death among PWID, nonwhite individuals and those who did not have a CD4+ exam registered at baseline, while MSM presented a lower risk (in both extended Cox model and frailty model). This model presented R 2 = 0.234. As expected, higher CD4+ counts at baseline and HAART uptake after AIDS diagnosis were stronger predictors of better survival over time.
When we analyzed the risk of AIDS-related death for each exposure category, different patterns were observed among MSM, heterosexuals and PWID. Covariates found to be independently and significantly associated with a higher survival among MSM and heterosexuals included: HAART uptake after diagnosis and CD4+ level (cells/mm 3 ) at baseline (the higher the CD4+, the longer the survival time). Non-whites presented a higher risk of dying in consequence of AIDS for both exposure categories. Those who did not have a CD4+ exam available at baseline had an increased risk of dying of AIDS among heterosexuals. The MSM model had an R 2 = 0.219 and heterosexuals had an R 2 = 0.242 (Table 4) .
For PWID, only HAART uptake and the higher CD4+ category "> 500" predicted a longer survival. The protective effect of HAART was lower for PWID (70%) when compared to other exposure categories. Non-white PWID had almost double risk of dying of AIDS among this group when compared to whites. This model had a higher R 2 (0.389), compared to all others. The variation among regions of residence was significant (as measured by the frailty effect), except for PWID (Table 4) .
Considering the frequencies of cases by Administrative Regions (AR), two clusters were observed: a larger one, comprising AR XIII (Méier), XV (Madureira), XVI ( Jacarepaguá), XVII (Bangu), XVIII (Campo Grande) and Realengo (XXXIII ), which together account for 34.6% of the total cases in the period; and a smaller one, involving AR IV (Botafogo) and V (Copacabana), which accounted for 11.3% of the cases in the period (Figure 1 ).
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Discussion
Several studies have reported substantial improvement in terms of prognosis and survival for PLWHA in the late post-HAART era, however our results documented auspicious findings vis-à-vis previous analysis. Among all cohorts under analysis, 14.1% had died in consequence of HIV/AIDS and we identified a median survival of 6.29 years. One of the first studies in the post-HAART era in Brazil 40 made evident a median survival of 5 months for cases diagnosed in 1980, of 18 months for those diagnosed in 1995 and of 58 months (4.8 years) for cases diagnosed in 1996. A study conducted in the Northeast Region of Brazil 41 with 597 individuals diagnosed in 1997-2004, found 1-year, 2-year and 5-year survival rates of 88%, 86% and 82%, respectively, and 75% of the patients actually survived for 5.5 years. In another Brazilian study with 2,091 patients diagnosed in 1998 and 1999 42 and carried out in the South and Southeast Regions, a survival time of 108 months (9 years) after AIDS diagnosis was documented for over 59% of patients from both regions. For both Cad. Saúde Pública 2018; 34(8):e00009617 Table 2 Clinical and sociodemographic characteristics of all individuals included in the study, for the total (N = 15,420) and according to each exposure category. Table 4 Hazard ratios of AIDS-related deaths for different transmission categories: MSM (n = 5,564), PWID (n = 498) and heterosexual (n = 9,358). Rio de Janeiro, 
months (5 years
). An Iranian cohort study 45 , with 585 patients diagnosed from 1997 to 2011, found a 1-year and a 5-year survival of 76% and 46%, respectively. Our findings documented a better scenario, with survival above 80% during the entire follow-up. These promising trends may be explained by the substantial improvement of HAART intake in Brazil and, specifically, in Rio de Janeiro during the study period. Our analysis identified that 62% of the population analyzed had received HAART or was under treatment, compared to 28.3% of the population evaluated in a nationwide study conducted in Brazil between 2000-2006 12 . AIDSrelated mortality decreased among heterosexuals from both genders and among MSM, with modest improvements among PWID.
Our findings corroborate previous Brazilian studies that also identified a higher risk of AIDSrelated death among non-whites patients 23, 46, 47 and those with lower education levels 48 .
The important prognostic value of high levels of CD4+ at baseline has been documented by several studies. A multicenter cohort study conducted with 24,037 patients treated between 2001-2010 in 4 HIV-clinics from Sub-Saharan Africa 49 reported better survival among people with CD4+ levels higher than 500 cells/μL at baseline. A study with 20,730 patients from 10 HIV-clinics in Uganda 50 also demonstrated that higher baseline CD4+ cell count at HAART initiation increases the likelihood of survival over time. In Brazil, late entry into HIV treatment has also been consistently associated with increased mortality risk 48, 51 . Corroborating those studies, our results identified HAART uptake and CD4+ > 500 at baseline as key predictors for improved survival, with protective effects of 81% and 77%, respectively.
Although the variance of the frailty effect was similar for both MSM and PWID (0.12), it was not significant among the latter, probably because of the small size of this group. PWID tend to live in underserved areas and many of them have unstable residence or are homeless. Mobility and lack of a stable residence usually precluded/compromised affiliation to local health programs and services, which have an essential role in the Brazilian public health system 52 .
Despite the relevance of our study and its findings, comprising a large number of AIDS cases from Rio de Janeiro city over a 12-year follow-up period, including clinical, laboratory and epidemiological data, this study has important limitations that need to be acknowledged. Those limitations are mostly related to the data sources used. A key problem might be the possibility that, due to AIDS-cases underreporting, SINAN failed to include a proportion of HIV-infected individuals. In an attempt to Cad. Saúde Pública 2018; 34 (8):e00009617 minimize the limitations resulting from underreporting, we used several datasets, which allowed us to retrieve a variety of clinical, laboratory and socio-demographic information.
Different kinds of information is collected by each dataset. For instance, upper-and middle-class patients may have had their exams reimbursed by private health insurance and prefer to have their exams performed in private laboratories (and therefore their data might not be available on SISCEL dataset), whereas the most marginalized and stigmatized segments might never access HIV-related treatment and care, being identified as "AIDS-case" only after AIDS-related death (and therefore identified only on the mortality dataset, SIM). Regardless of where medical care is received, all PLWHA receive their antiretroviral drugs through SUS, the single accredited source of ART in Brazil (which are not sold in pharmacies or drugstores); hence, all patients under HAART should be registered in the SICLOM database. Linkage is nowadays a key procedure in the analysis of Brazil's AIDS databases, a strategy that allows a better and more efficient utilization of available data.
If new AIDS cases were exclusively tracked with the help of SINAN-AIDS (AIDS cases database), this would generate spurious conclusions, pointing to a putative drastic reduction in the number of AIDS cases in recent years. What is happening, in fact, is a gradual increase in reports which are exclusively available at other databases, whose primary purpose is not epidemiological surveillance, but rather the ongoing assessment of laboratory exams and the delivery of medicine. Information about day-to-day logistics of medicines procurement, prescription and delivery of medicines, as well as the routine of laboratory exams, do not exist in most countries as nationwide databases. From this point of view, the Brazilian effort is commendable. On the other hand, such databases should not replace surveillance systems, as has been occurring in Brazil, with adverse consequences for both surveillance itself and the monitoring of routine procedures.
In order to evaluate a possible effect of selection bias, we analyzed the characteristics of 27,779 patients who didn't have information about their exposure category and were not included in our survival analysis. These patients had similar characteristics to the 15,420 patients herein analyzed in terms of sex, age, ethnicity, and education levels (data not shown).
It is important to highlight that the criteria for antiretroviral therapy prescription underwent changes throughout the study period, and the initial criteria differed from the current ones. Therefore, it is possible that some of the patients living with HIV did not receive HAART because they did not meet the valid criteria for initiation of therapy at the time of their diagnosis. However, over time, not only were these criteria progressively updated, but several patients progressed to compatible clinical conditions with these successive criteria. This is a universal limitation, considering that is not possible to explore these complex interactions unless we have a database that could record the successive "status" of each individual and the successive changes of criteria, as well as the advent of new drugs and new therapeutic regimens.
Despite the aforementioned limitations, our results add to existing evidence and could guide better local strategies targeting PLWHA in Rio de Janeiro. It should also be highlighted here the importance of the Brazilian HIV/AIDS response and the broad availability of national and local dataset that provides clinical, laboratory and socio-demographic information of all patients under treatment and care at public health care facilities.
Conclusions
Some important inequalities persist in access to treatment, resulting in disparate impacts on mortality among exposure categories. PWID, non-whites and people without at least the first CD4+ exam registered at baseline had higher AIDS-related mortality. HAART early intake presented a key protective effect and allowed us to highlight the urgent need to address the issue of late entry into HIV care in the local and national levels.
Despite these persistent disparities, mortality decreased significantly during the period for all categories under analysis, and the overall positive impact of HAART on survival has been dramatic. 
